96 related articles for article (PubMed ID: 19111471)
1. Inhibition of the PCAF histone acetyl transferase and cell proliferation by isothiazolones.
Dekker FJ; Ghizzoni M; van der Meer N; Wisastra R; Haisma HJ
Bioorg Med Chem; 2009 Jan; 17(2):460-6. PubMed ID: 19111471
[TBL] [Abstract][Full Text] [Related]
2. Reactivity of isothiazolones and isothiazolone-1-oxides in the inhibition of the PCAF histone acetyltransferase.
Ghizzoni M; Haisma HJ; Dekker FJ
Eur J Med Chem; 2009 Dec; 44(12):4855-61. PubMed ID: 19683843
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of isothiazol-3-one derivatives as inhibitors of histone acetyltransferases (HATs).
Gorsuch S; Bavetsias V; Rowlands MG; Aherne GW; Workman P; Jarman M; McDonald E
Bioorg Med Chem; 2009 Jan; 17(2):467-74. PubMed ID: 19101154
[TBL] [Abstract][Full Text] [Related]
4. Histone acetyl transferases as emerging drug targets.
Dekker FJ; Haisma HJ
Drug Discov Today; 2009 Oct; 14(19-20):942-8. PubMed ID: 19577000
[TBL] [Abstract][Full Text] [Related]
5. Isothiazolones; thiol-reactive inhibitors of cysteine protease cathepsin B and histone acetyltransferase PCAF.
Wisastra R; Ghizzoni M; Maarsingh H; Minnaard AJ; Haisma HJ; Dekker FJ
Org Biomol Chem; 2011 Mar; 9(6):1817-22. PubMed ID: 21267493
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological testing of novel pyridoisothiazolones as histone acetyltransferase inhibitors.
Furdas SD; Shekfeh S; Bissinger EM; Wagner JM; Schlimme S; Valkov V; Hendzel M; Jung M; Sippl W
Bioorg Med Chem; 2011 Jun; 19(12):3678-89. PubMed ID: 21353783
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of PCAF histone acetyltransferase and cytotoxic effect of N-acylanthranilic acids.
Park WJ; Ma E
Arch Pharm Res; 2012 Aug; 35(8):1379-86. PubMed ID: 22941480
[TBL] [Abstract][Full Text] [Related]
8. Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity.
Stimson L; Rowlands MG; Newbatt YM; Smith NF; Raynaud FI; Rogers P; Bavetsias V; Gorsuch S; Jarman M; Bannister A; Kouzarides T; McDonald E; Workman P; Aherne GW
Mol Cancer Ther; 2005 Oct; 4(10):1521-32. PubMed ID: 16227401
[TBL] [Abstract][Full Text] [Related]
9. Identification of 4-hydroxyquinolines inhibitors of p300/CBP histone acetyltransferases.
Mai A; Rotili D; Tarantino D; Nebbioso A; Castellano S; Sbardella G; Tini M; Altucci L
Bioorg Med Chem Lett; 2009 Feb; 19(4):1132-5. PubMed ID: 19144517
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of p300 specific histone acetyltransferase inhibition by small molecules.
Arif M; Pradhan SK; Thanuja GR; Vedamurthy BM; Agrawal S; Dasgupta D; Kundu TK
J Med Chem; 2009 Jan; 52(2):267-77. PubMed ID: 19086895
[TBL] [Abstract][Full Text] [Related]
11. Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative.
Ghizzoni M; Boltjes A; Graaf Cd; Haisma HJ; Dekker FJ
Bioorg Med Chem; 2010 Aug; 18(16):5826-34. PubMed ID: 20655754
[TBL] [Abstract][Full Text] [Related]
12. Identification of long chain alkylidenemalonates as novel small molecule modulators of histone acetyltransferases.
Sbardella G; Castellano S; Vicidomini C; Rotili D; Nebbioso A; Miceli M; Altucci L; Mai A
Bioorg Med Chem Lett; 2008 May; 18(9):2788-92. PubMed ID: 18434144
[TBL] [Abstract][Full Text] [Related]
13. Bisubstrate analogue structure-activity relationships for p300 histone acetyltransferase inhibitors.
Sagar V; Zheng W; Thompson PR; Cole PA
Bioorg Med Chem; 2004 Jun; 12(12):3383-90. PubMed ID: 15158807
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.
Lasko LM; Jakob CG; Edalji RP; Qiu W; Montgomery D; Digiammarino EL; Hansen TM; Risi RM; Frey R; Manaves V; Shaw B; Algire M; Hessler P; Lam LT; Uziel T; Faivre E; Ferguson D; Buchanan FG; Martin RL; Torrent M; Chiang GG; Karukurichi K; Langston JW; Weinert BT; Choudhary C; de Vries P; Van Drie JH; McElligott D; Kesicki E; Marmorstein R; Sun C; Cole PA; Rosenberg SH; Michaelides MR; Lai A; Bromberg KD
Nature; 2017 Oct; 550(7674):128-132. PubMed ID: 28953875
[TBL] [Abstract][Full Text] [Related]
15. A dual-mode fluorescence strategy for screening HAT modulators.
Xie N; Elangwe EN; Asher S; Zheng YG
Bioconjug Chem; 2009 Feb; 20(2):360-6. PubMed ID: 19146394
[TBL] [Abstract][Full Text] [Related]
16. 15-Deoxy-Delta(12,14)-prostaglandin J(2) impairs the functions of histone acetyltransferases through their insolubilization in cells.
Hironaka A; Morisugi T; Kawakami T; Miyagi I; Tanaka Y
Biochem Biophys Res Commun; 2009 Dec; 390(2):290-4. PubMed ID: 19799872
[TBL] [Abstract][Full Text] [Related]
17. Curcumin is an inhibitor of p300 histone acetylatransferase.
Marcu MG; Jung YJ; Lee S; Chung EJ; Lee MJ; Trepel J; Neckers L
Med Chem; 2006 Mar; 2(2):169-74. PubMed ID: 16787365
[TBL] [Abstract][Full Text] [Related]
18. Expression of PCAF, p300 and Gcn5 and more highly acetylated histone H4 in pediatric tumors.
Armas-Pineda C; Arenas-Huertero F; Pérezpeñia-Diazconti M; Chico-Ponce de León F; Sosa-Sáinz G; Lezama P; Recillas-Targa F
J Exp Clin Cancer Res; 2007 Jun; 26(2):269-76. PubMed ID: 17725108
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of benzamides related to anacardic acid and their histone acetyltransferase (HAT) inhibitory activities.
Souto JA; Conte M; Alvarez R; Nebbioso A; Carafa V; Altucci L; de Lera AR
ChemMedChem; 2008 Sep; 3(9):1435-42. PubMed ID: 18537201
[TBL] [Abstract][Full Text] [Related]
20. Azide-alkyne cycloaddition affording enzymatically tunable bisubstrate based inhibitors of histone acetyltransferase PCAF.
van Ameijde J; Zwiebel AP; Ruijtenbeek R; Liskamp RM
Bioorg Med Chem Lett; 2014 Jan; 24(1):113-6. PubMed ID: 24345448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
